- Home
- NMRA vs BLDE Comparison
NMRA vs BLDE Comparison
Compare NMRA & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- BLDE
- Stock Information
- Founded
- NMRA 2019
- BLDE 2014
- Country
- NMRA United States
- BLDE United States
- Employees
- NMRA N/A
- BLDE N/A
- Industry
- NMRA
- BLDE Aerospace
- Sector
- NMRA
- BLDE Consumer Discretionary
- Exchange
- NMRA Nasdaq
- BLDE Nasdaq
- Market Cap
- NMRA 121.0M
- BLDE 285.2M
- IPO Year
- NMRA 2023
- BLDE N/A
- Fundamental
- Price
- NMRA $0.84
- BLDE $4.18
- Analyst Decision
- NMRA Buy
- BLDE Strong Buy
- Analyst Count
- NMRA 8
- BLDE 2
- Target Price
- NMRA $9.29
- BLDE $6.25
- AVG Volume (30 Days)
- NMRA 1.4M
- BLDE 855.2K
- Earning Date
- NMRA 08-05-2025
- BLDE 08-06-2025
- Dividend Yield
- NMRA N/A
- BLDE N/A
- EPS Growth
- NMRA N/A
- BLDE N/A
- EPS
- NMRA N/A
- BLDE N/A
- Revenue
- NMRA N/A
- BLDE $251,485,000.00
- Revenue This Year
- NMRA N/A
- BLDE $5.58
- Revenue Next Year
- NMRA N/A
- BLDE $8.56
- P/E Ratio
- NMRA N/A
- BLDE N/A
- Revenue Growth
- NMRA N/A
- BLDE 8.67
- 52 Week Low
- NMRA $0.61
- BLDE $2.35
- 52 Week High
- NMRA $17.19
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- NMRA 52.19
- BLDE 62.55
- Support Level
- NMRA $0.72
- BLDE $3.94
- Resistance Level
- NMRA $0.85
- BLDE $4.22
- Average True Range (ATR)
- NMRA 0.07
- BLDE 0.20
- MACD
- NMRA -0.01
- BLDE 0.00
- Stochastic Oscillator
- NMRA 62.35
- BLDE 91.04
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.